Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    N Engl J Med. 2004 Dec 2;351(23):2403-7.

    Mutation of CEBPA in familial acute myeloid leukemia.

    Source

    Medical Oncology Unit, Cancer Research UK, Barts and the London School of Medicine and Dentistry, St. Bartholomew's Hospital, West Smithfield, London. matthew.smith@cancer.org.uk

    Abstract

    We describe a family in whom three members affected by acute myeloid leukemia (AML) had an identical, 212delC mutation in CEBPA, the gene encoding the granulocytic differentiation factor C/EBPalpha. Unaffected family members did not have this mutation. Latent periods of 10, 18, and 30 years elapsed before the onset of overt leukemia in the three patients. One of them had a second CEBPA mutation, but only at the time of diagnosis. All three patients are currently well, with no abnormalities in the bone marrow. CEBPA mutation is apparently the primary event in the development of AML in this family.

    Copyright 2004 Massachusetts Medical Society.

    Comment in

    PMID:
    15575056
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for Atypon

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk